Oneness announces the resolution of the Board of Directors on the Record Date of Capital Increase for the issuance of Restricted Employee Shares in 2023.

Published Date:2024-08-12

Original Link:https://www.onenessbio.com/en/news_detail311_2.htm

Statement
No	2	Date of announcement	2024/08/12	Time of announcement	16:29:17
Subject	Oneness announces the resolution of the Board of Directors on the Record Date of Capital Increase for the issuance of Restricted Employee Shares in 2023.
To which item it meets	paragraph 53			Date of events	2024/08/12
Date of occurrence of the event: 2024/08/12 Company name: ONENESS BIOTECH CO., LTD. Relationship to the Company (please enter ”head office” or ”subsidiaries”): head office Reciprocal shareholding ratios: NA Cause of occurrence: (1)The shareholders meeting on 2023/4/18 resolved to issue 1,500,000 restricted employee shares, with a par value of NT$10. This was filed to the Financial Supervisory Commission (FSC) and effective according to the FSC letter No.1120344676 on 2023/5/31. (2)The company is based on the Company’s ” Procedures for Issuance of Restricted Stocks to Employees in 2023”to issue 120,000 restricted employee shares in 2023. This issuance will be Issued for NT$30 per share, with the capital increase record date set for 2024/08/16. Subsequently, If there are any matters not mentioned, it is proposed to seek authorization from the company’s board of directors for the chairman to make adjustments with full authority. Countermeasures: NA Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.): None